Exelixis Inc (EXEL)

Exchange
NASDAQ
Symbol
EXEL
Sector
Trade & Services
Industry
Services-commercial Physical & Biological Research
Description
Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development, and commercialization of new drugs to treat cancers in the United States. The company is headquartered in Alameda, California.
Country
USA

Stock price

At close: July 11, 2025

  • Open
    45.00
  • High
    45.41
  • Low
    44.77
  • Close
    44.86
  • Volume
    2,063,670

Financial ratios

Dec 31, 2024